Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology
Abstract
There is increasing use of Phase I statistical designs to find a dose that causes rapidly emerging and particularly concerning severe or life-threatening toxicities (dose-limiting toxicities, DLTs) in a specified percent of patients most commonly 25%. While a convenient statistical framework, the foundation for selecting any specified target DLT rate, and its relevance to the recommended Phase II dose is generally lacking.We surveyed 78 medical...
Paper Details
Title
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology
Published Date
Dec 1, 2020
Journal
Volume
44
Issue
6
Pages
100583 - 100583
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History